You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Phosphatidylinositol 3-kinase

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Breast Cancer Trial in East Melbourne (BYl719)

Completed
  • Metastatic Breast Cancer
  • East Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Aug 11, 2022

A NIS of Alpelisib in Combination With Fulvestrant in

Not yet recruiting
  • Hormone Receptor Positive HER2 Negative Breast Cancer With a PIK3CA Mutation
  • Alpelisib
  • Fulvestrant
  • (no location specified)
Aug 9, 2022

Follicular Lymphoma Trial in Germany (Copanlisib, Obinutuzumab)

Recruiting
  • Follicular Lymphoma
  • München, Bavaria, Germany
  • +39 more
May 19, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Follicular Lymphoma Trial in Australia, China (BGB-10188,

Recruiting
  • Chronic Lymphocytic Leukemia
  • +9 more
  • Adelaide, Australia
  • +12 more
Jan 6, 2023

Safety Issues, Efficacy, Self Trial in Beijing (TQB3525)

Active, not recruiting
  • Safety Issues
  • Efficacy, Self
  • Beijing, China
    Peking University Shougang Hospital
Dec 29, 2020

Mixed Tumor, Malignant Trial in United States (BAY806946)

Recruiting
  • Mixed Tumor, Malignant
  • Birmingham, Alabama
  • +20 more
Jan 20, 2023

Activated PI3K-delta Syndrome, Immunodeficiency Primary Trial in Shanghai (Rapamycin)

Recruiting
  • Activated PI3K-delta Syndrome
  • Immunodeficiency Primary
  • Shanghai, Shanghai, China
  • +1 more
Mar 21, 2022

Cushing Disease Trial (Fimepinostat)

Not yet recruiting
  • Cushing Disease
  • (no location specified)
Jul 31, 2023

Marginal Zone Lymphoma, Follicular Lymphoma Trial in China (HMPL-689)

Recruiting
  • Marginal Zone Lymphoma
  • Follicular Lymphoma
  • Hefei, Anhui, China
  • +35 more
Jun 7, 2021

Advanced Hepatocellular Carcinoma Trial in La Jolla (SF1126, Nivolumab)

Terminated
  • Advanced Hepatocellular Carcinoma
  • La Jolla, California
    UC San Diego Moores Cancer Center
May 11, 2022

Thymidine Kinase 2 Deficiency Trial (MT1621)

Withdrawn
  • Thymidine Kinase 2 Deficiency
  • (no location specified)
Aug 16, 2022

Xospata in Relapsed or Refractory Acute Myeloid Leukemia With

Recruiting
  • Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation
  • Gilteritinib Exposure
  • Goyang-si, Gyeonggi-do, Korea, Republic of
  • +4 more
Aug 18, 2022

Non Small Cell Lung Cancer Trial in Mexico City (Metformin Hydrochloride, Placebo)

Recruiting
  • Non Small Cell Lung Cancer
  • Metformin Hydrochloride
  • Placebo
  • Mexico City, Mexico
    Instituto Nacional de Cancerologia
Jul 21, 2022

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial in Boston (Iadademstat, Gilteritinib Oral Tablet)

Recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Acute Myeloid Leukemia Refractory
  • Boston, Massachusetts
  • +2 more
Jan 18, 2023

Solid Tumors, Adult, PIK3CA Mutation-Related Tumors, PIK3CA Mutation Trial in San Francisco (Alpelisib, Carboplatin,

Not yet recruiting
  • Solid Tumors, Adult
  • +7 more
  • San Francisco, California
    University of California, San Francisco
Jul 21, 2022

HR+, HER2-, Advanced Breast Cancer Trial (alpelisib)

Available
  • HR+, HER2-, Advanced Breast Cancer
  • (no location specified)
Jul 5, 2022

Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD)
  • Cincinnati, Ohio
  • +18 more
Jan 20, 2023

Pediatric Pyruvate Kinase Deficiency, Pediatric Hemolytic Anemia Trial in Barcelona, Madrid (Mitapivat, Mitapivat-matching )

Recruiting
  • Pediatric Pyruvate Kinase Deficiency
  • Pediatric Hemolytic Anemia
  • Barcelona, Spain
  • +1 more
Aug 8, 2022

APDS Trial in Netherlands, United States (Leniolisib)

Not yet recruiting
  • APDS
  • Los Angeles, California
  • +4 more
Jan 12, 2023

Adult Chronic Lymphocytic Leukemia Receiving Oral Venetoclax

Recruiting
  • Chronic Lymphocytic Leukemia
    • London, London, City Of, United Kingdom
    • +9 more
    Jan 13, 2023

    Acute Myeloid Leukemia With FLT3/ITD Mutation Trial (XY0206, Salvage Chemotherapy)

    Not yet recruiting
    • Acute Myeloid Leukemia With FLT3/ITD Mutation
    • (no location specified)
    May 24, 2023

    Tissue Samples From Breast Cancer Who Were Treated on Clinical

    Completed
    • Breast Cancer
    • diagnostic laboratory biomarker analysis
    • (no location specified)
    Jul 1, 2019

    Mild Cognitive Impairment Trial (Lithium Carbonate)

    Completed
    • Mild Cognitive Impairment
    • Lithium Carbonate
    • (no location specified)
    Aug 5, 2021

    Lymphoma, Non-Hodgkin Lymphoma Trial in Munich (PQR309)

    Completed
    • Lymphoma
    • Non-Hodgkin Lymphoma
    • Munich, Bavaria, Germany
      Medizinische Klinik und Poliklinik III
    Jun 27, 2019

    Pediatric Pyruvate Kinase Deficiency, Pediatric Hemolytic Anemia Trial in Spain, United States (Mitapivat, Mitapivat-matching )

    Recruiting
    • Pediatric Pyruvate Kinase Deficiency
    • Pediatric Hemolytic Anemia
    • Phoenix, Arizona
    • +3 more
    Aug 8, 2022